Jhonathan Duarte
Obstetrics & Gynecology · Miami, FLNPI 1326451188
Payments from drug & device makers
Across 109 payments — averaging $23.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$752
- Shield Therapeutics Inc$584
- Evofem Biosciences, Inc.$213
- Mayne Pharma Commercial LLC$145
- Vertical Pharmaceuticals, LLC$130
- Hologic Sales And Service, LLC$117
- plus $635 from 18 others
What the payments were for
- Food & beverage$2,563100%
- Gifts$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $752 |
| Shield Therapeutics Inc | 11 | $584 |
| Evofem Biosciences, Inc. | 11 | $213 |
| Mayne Pharma Commercial LLC | 5 | $145 |
| Vertical Pharmaceuticals, LLC | 8 | $130 |
| Hologic Sales And Service, LLC | 5 | $117 |
| Coopersurgical, Inc. | 4 | $71 |
| Therapeuticsmd, Inc. | 3 | $60 |
| Mission Pharmacal Company | 4 | $59 |
| Millicent US Inc | 3 | $55 |
| Kowa Pharmaceuticals America, Inc. | 2 | $49 |
| Exeltis, USA Inc. | 2 | $45 |
| Pfizer | 2 | $43 |
| Organon | 2 | $42 |
| Avion Pharmaceuticals | 2 | $33 |
| Merck | 2 | $30 |
| Daiichi Sankyo Inc. | 2 | $28 |
| Organogenesis Inc. | 1 | $20 |
| Scynexis, Inc. | 1 | $20 |
| BD | 1 | $19 |
| Axonics, Inc. | 1 | $18 |
| Duchesnay USA Incorporated | 1 | $16 |
| Minerva Surgical, Inc | 1 | $14 |
| Ascend Therapeutics US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACCRUFER$130
How this compares
$2,575 in reported general payments places this provider in the 75th percentile of 2,438 obstetrics & gynecology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 16 | $6,286 |
| ImvexxyEstradiol | 13 | $2,819 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $43 | $6,28616 claims |
| Therapeuticsmd, Inc.Imvexxy | $60 | $2,81913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,438 obstetrics & gynecology providers in Florida.
Other obstetrics & gynecology in Miami
- Guillermo LievanoMiami$2.5M
- Victoria BedellMiami$1.4M
- Sarah BedellMiami$1.1M
- Luis LeyvaMiami$754K
- Joanna BedellMiami$575K
- Julio ArronteMiami$290K
- Beatrice HeckerMiami$172K
- Samuel LedermanLake Worth$13.4M
- Richard MyersJacksonville$2.7M
- Steven McCarusCelebration$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.